company background image
603079 logo

Zhejiang Shengda Bio-Pharm SHSE:603079 Stock Report

Last Price

CN¥15.02

Market Cap

CN¥2.6b

7D

-22.1%

1Y

5.1%

Updated

28 Nov, 2024

Data

Company Financials

Zhejiang Shengda Bio-Pharm Co., Ltd.

SHSE:603079 Stock Report

Market Cap: CN¥2.6b

603079 Stock Overview

Develops, produces, and sells food and feed additives for pharmaceutical, nutritional, food, and animal feed industry. More details

603079 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Zhejiang Shengda Bio-Pharm Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Zhejiang Shengda Bio-Pharm
Historical stock prices
Current Share PriceCN¥15.02
52 Week HighCN¥21.21
52 Week LowCN¥7.01
Beta0.50
11 Month Change4.52%
3 Month Change37.55%
1 Year Change5.11%
33 Year Change-10.86%
5 Year Change-44.81%
Change since IPO35.48%

Recent News & Updates

Subdued Growth No Barrier To Zhejiang Shengda Bio-Pharm Co., Ltd. (SHSE:603079) With Shares Advancing 28%

Oct 28
Subdued Growth No Barrier To Zhejiang Shengda Bio-Pharm Co., Ltd. (SHSE:603079) With Shares Advancing 28%

What Zhejiang Shengda Bio-Pharm Co., Ltd.'s (SHSE:603079) 27% Share Price Gain Is Not Telling You

Aug 08
What Zhejiang Shengda Bio-Pharm Co., Ltd.'s (SHSE:603079) 27% Share Price Gain Is Not Telling You

Recent updates

Subdued Growth No Barrier To Zhejiang Shengda Bio-Pharm Co., Ltd. (SHSE:603079) With Shares Advancing 28%

Oct 28
Subdued Growth No Barrier To Zhejiang Shengda Bio-Pharm Co., Ltd. (SHSE:603079) With Shares Advancing 28%

What Zhejiang Shengda Bio-Pharm Co., Ltd.'s (SHSE:603079) 27% Share Price Gain Is Not Telling You

Aug 08
What Zhejiang Shengda Bio-Pharm Co., Ltd.'s (SHSE:603079) 27% Share Price Gain Is Not Telling You

Revenues Working Against Zhejiang Shengda Bio-Pharm Co., Ltd.'s (SHSE:603079) Share Price Following 26% Dive

Jun 12
Revenues Working Against Zhejiang Shengda Bio-Pharm Co., Ltd.'s (SHSE:603079) Share Price Following 26% Dive

Zhejiang Shengda Bio-Pharm Co., Ltd.'s (SHSE:603079) 30% Dip In Price Shows Sentiment Is Matching Revenues

Apr 25
Zhejiang Shengda Bio-Pharm Co., Ltd.'s (SHSE:603079) 30% Dip In Price Shows Sentiment Is Matching Revenues

Zhejiang Shengda Bio-Pharm Co., Ltd. (SHSE:603079) Surges 31% Yet Its Low P/S Is No Reason For Excitement

Mar 08
Zhejiang Shengda Bio-Pharm Co., Ltd. (SHSE:603079) Surges 31% Yet Its Low P/S Is No Reason For Excitement

Shareholder Returns

603079CN PharmaceuticalsCN Market
7D-22.1%-1.4%-2.0%
1Y5.1%-6.0%4.6%

Return vs Industry: 603079 exceeded the CN Pharmaceuticals industry which returned -6% over the past year.

Return vs Market: 603079 matched the CN Market which returned 4.6% over the past year.

Price Volatility

Is 603079's price volatile compared to industry and market?
603079 volatility
603079 Average Weekly Movement9.1%
Pharmaceuticals Industry Average Movement7.4%
Market Average Movement8.4%
10% most volatile stocks in CN Market12.6%
10% least volatile stocks in CN Market5.6%

Stable Share Price: 603079 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 603079's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a1,032Bin Zhouwww.sd-pharm.com

Zhejiang Shengda Bio-Pharm Co., Ltd. develops, produces, and sells food and feed additives for pharmaceutical, nutritional, food, and animal feed industry. It offers vitamins, such as biotin and folic acid; biological preservatives, including nisin and natamycin; and intermediate APIs. The company is based in Tiantai, China.

Zhejiang Shengda Bio-Pharm Co., Ltd. Fundamentals Summary

How do Zhejiang Shengda Bio-Pharm's earnings and revenue compare to its market cap?
603079 fundamental statistics
Market capCN¥2.59b
Earnings (TTM)-CN¥28.70m
Revenue (TTM)CN¥792.17m

3.2x

P/S Ratio

-88.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
603079 income statement (TTM)
RevenueCN¥792.17m
Cost of RevenueCN¥690.58m
Gross ProfitCN¥101.59m
Other ExpensesCN¥130.29m
Earnings-CN¥28.70m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.17
Gross Margin12.82%
Net Profit Margin-3.62%
Debt/Equity Ratio18.8%

How did 603079 perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

-33%

Payout Ratio